A. Chiodera

发表

'Baggage malaria' in Italy: cryptic malaria explained?

F. Castelli, A. Matteelli, G. Carosi, 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.

A. d’Arminio Monforte, V. Vullo, A. Antinori, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-Restrictive Antimicrobial Stewardship Program in a General and Emergency Surgery Unit.

A. Chiodera, M. Sartelli, L. Scoccia, 2016, Surgical infections.

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment.

G. Carosi, M. Puoti, F. Gargiulo, 2000, The Journal of infectious diseases.

CONCISE COMMUNICATION Liver Damage and Kinetics of Hepatitis C Virus and Human Immunodeﬁciency Virus Replication during the Early Phases of Combination Antiretroviral Treatment

G. Carosi, M. Puoti, A. Chiodera, 2022 .

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Molecular Diagnosis of Malaria Infection: A Survey in a Hospital in Central Italy

P. Rossi, I. Ricci, C. Damiani, 2017 .

Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

G. Ippolito, M. Capobianchi, A. Monforte, 2005, Antiviral Therapy.

Recent Acquired STD and the Use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): Analysis of the Incidence of Newly Acquired Hepatitis B Infection and Syphilis

A. d’Arminio Monforte, C. Tincati, F. T. P. Group, 2008, Infection.

Antiretroviral therapy with association alpha-interferon + AZT in HIV-positive subjects. Preliminary report of an ongoing clinical trial. The Infectivologists HIV/Interferon Study Group.

G. Carosi, A. Chiodera, P. Milini, 1992, Pharmacological research.

Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome.

A. Benedetti, H. Dalton, M. Marzioni, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment

E. Nicastri, A. Antinori, G. Marchetti, 2013, AIDS.

Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?

A. Antinori, A. De Luca, A. Monforte, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.

A. Lazzarin, K. Facey, M. Andreoni, 1996, Antiviral therapy.

Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis.

M. Massari, G. Ippolito, V. Puro, 2001, Journal of biological regulators and homeostatic agents.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

A proposal for a comprehensive approach to infections across the surgical pathway

M. Vivarelli, M. D'Errico, D. Francisci, 2020, World Journal of Emergency Surgery.

Long‐term benefit of genotypic‐guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients

F. Castelli, G. Carosi, F. Moretti, 2001, Journal of clinical laboratory analysis.

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.

D. Francisci, F. Baldelli, A. Chiodera, 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.

D. Francisci, F. Baldelli, A. Chiodera, 2007, European journal of gastroenterology & hepatology.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.